author-photo

George E. Peoples

Uniformed Services University of the Health Sciences
San Antonio Military Medical Center
University of Texas MD Anderson Cancer Center

277

Papers

4610

Citations

Citation Trend

Filter By

Papers (277) Sort By

Journal Conference Others

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma.

2021 OncoTargets and Therapy
Show All
- Source
- Cite
- Save
Citations (0)
The influence of harvest method on dendritic cell function and clinical outcomes in a randomized trial of a dendritic cell vaccine to prevent recurrences in high-risk melanoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An Autologous Tumor Lysate Dendritic Cell Vaccine Is Most Effective in Recurrent, Advanced-Stage Melanoma in a Randomized Controlled Trial

2021 Journal of The American College of Surgeons
Show All
- Source
- Cite
- Save
Citations (0)
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

2021 Melanoma Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase I Trial of Encapsulated Rapamycin in Prostate Cancer Patients Under Active Surveillance to Prevent Progression.

2021 Cancer Prevention Research
Show All
- Source
- Cite
- Save
Citations (2)
Interim results of viagenpumatucel-L (HS-110) plus nivolumab in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC) in two treatment settings.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.

2021 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
542 Randomized trial of tumor lysate particle only vaccine vs. tumor lysate particle-loaded, dendritic cell vaccine to prevent recurrence of resected stage III/IV melanoma: 36-month analysis

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.

2021 Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (7)